Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Immune System Changes During Covid-19 Recovery Play Key Role in Determining Disease Severity Publisher Pubmed



Fathi F1 ; Sami R2 ; Mozafarpoor S3 ; Hafezi H4 ; Motedayyen H5 ; Arefnezhad R6, 7 ; Eskandari N1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Internal Medicine, School of Medicine, Khorshid Hospital, Isfahan University of Medical Science, Isfahan, Iran
  3. 3. Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Dermatology, Hormozgan University of Medical Sciences, Hormozgan, Iran
  5. 5. Autoimmune Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran
  6. 6. Halal Research Center of IRI, FDA, Tehran, Iran
  7. 7. Department of Anatomy, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Source: International Journal of Immunopathology and Pharmacology Published:2020


Abstract

Coronavirus disease 2019 (COVID-19), an acute respiratory infection, is largely associated with dysregulation and impairment of the immune system. This study investigated how the immune system changes were related to disease severity in COVID-19 patients. The frequencies of different immune cells and levels of pro- and anti-inflammatory cytokines in whole blood of participants were determined by flow cytometry and enzyme-linked immunosorbent assay, respectively. The values of other inflammatory agents were also studied. In the late recovery stage, unlike CD56high CD16+/− NK cells and monocytes, CD56low CD16+ NK cell numbers were increased (P < 0.0001–0.05). Th1, Th2, and Th17 cell percentages were significantly lower in patients than healthy control (P < 0.0001–0.05), while their frequencies were increased following disease recovery (P < 0.0001–0.05). The numbers of Tregs, activated CD4+ T cells, and exhausted CD8+ T cells were significantly decreased during a recovery (P < 0.0001–0.05). No significant change was observed in exhausted CD4+ T cell number during a recovery (P > 0.05). B cell showed an increased percentage in patients compared to healthy subjects (P < 0.0001–0.05), whereas its number was reduced following recovery (P < 0.0001–0.05). IL-1α, IL-1β, IL-6, TNF-α, and IL-10 levels were significantly decreased in the late recovery stage (P < 0.0001–0.05). However, TGF-β1 level was not significantly changed during the recovery (P > 0.05). Lymphocyte numbers in patients were significantly decreased (P < 0.001), unlike ESR value (P < 0.001). Lymphocyte number was negatively correlated to ESR value and Th2 number (P < 0.05), while its association with monocyte was significantly positive at the first day of recovery (P < 0.05). The immune system changes during the disease recovery to improve and regulate immune responses and thereby may associate with the reduction in disease severity. © The Author(s) 2020.
Related Docs
View other Related Docs
1. Characterizing the Immune Responses of Those Who Survived or Succumbed to Covid-19: Can Immunological Signatures Predict Outcome?, Cytokine (2021)
2. Sars-Cov-2 (Covid-19): New Discoveries and Current Challenges, Applied Sciences (Switzerland) (2020)
3. Potential Immune Indicators for Predicting the Prognosis of Covid-19 and Trauma: Similarities and Disparities, Frontiers in Immunology (2022)
4. Nervous System Involvement in Covid-19: A Review of the Current Knowledge, Molecular Neurobiology (2021)
5. Cytokines and Micrornas in Sars-Cov-2: What Do We Know?, Molecular Therapy Nucleic Acids (2022)
6. Cancer Occurrence As the Upcoming Complications of Covid-19, Frontiers in Molecular Biosciences (2022)
7. Conceptual Framework for Sars-Cov-2-Related Lymphopenia, Advanced Biomedical Research (2022)
8. The Role of Cytokine Profile and Lymphocyte Subsets in the Severity of Coronavirus Disease 2019 (Covid-19): A Systematic Review and Meta-Analysis, Life Sciences (2020)
Experts (# of related papers)
View all Related Experts
Ramin Sami (6)
Behrooz Ataei (6)
Other Related Docs
9. Diagnostic Value of Natural Killer Cells, Cd56+ Cd16+ Natural Killer Cells, Nlrp3, and Lactate Dehydrogenase in Severe/Critical Covid-19: A Prospective Longitudinal Study According to the Severe/Critical Covid-19 Definitions, Viral Immunology (2022)
10. Mesenchymal Stem Cells: A Potent Cell Source for Covid-19, Coronaviruses (2021)
11. Decrease of Tregs Cells and Increase of Exhausted Treg Cells As the Predictors of Covid19 Severity, Journal of Clinical Virology Plus (2024)
12. Nanobased Platforms for Diagnosis and Treatment of Covid-19: From Benchtop to Bedside, ACS Biomaterials Science and Engineering (2021)
13. Regenerative Medicine in Covid-19 Treatment: Real Opportunities and Range of Promises, Stem Cell Reviews and Reports (2021)
14. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
15. The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations During the Covid-19 Pandemic, Biomolecules (2021)
16. Immune Responses to Corona Family Viruses and Vaccine Strategies, Journal of Isfahan Medical School (2020)
17. The Kinetics of Inhibitory Immune Checkpoints During and Post-Covid-19: The Knowns and Unknowns, Clinical and Experimental Medicine (2023)
18. The Covid-19 Pandemic: A Systematic Review of the Current Evidence; [Пандемия Covid-19: Систематический Обзор Современных Данных], Russian Journal of Infection and Immunity (2020)
19. A Narrative Review of Covid-19: The New Pandemic Disease, Iranian Journal of Medical Sciences (2020)
20. Current Status of Covid-19 Pandemic; Characteristics, Diagnosis, Prevention, and Treatment, Journal of Research in Medical Sciences (2020)
21. Epidemiology, Virology, Clinical Features, Diagnosis, and Treatment of Sars-Cov-2 Infection, Journal of Experimental and Clinical Medicine (Turkey) (2021)
22. T-Cell Immunophenotyping in Covid-19 Pneumonia, Journal of Research in Medical Sciences (2021)
23. Hemoperfusion As a Supportive Treatment in a Covid-19 Patient With Late Pulmonary Thromboembolism: A Case Report, International Medical Case Reports Journal (2020)
24. Gastrointestinal and Renal Complications in Sars-Cov-2-Infected Patients: Role of Immune System, Scandinavian Journal of Immunology (2021)
25. Investigating Methods for Coronavirus Disease 2019 Control: A Systematic Review, Polish Annals of Medicine (2021)
26. Successful Recovery of a Child With Covid-19-Induced Secondary Hemophagocytic Lymphohistiocytosis, Archives of Pediatric Infectious Diseases (2022)
27. Association of Lymphocyte Subsets With Mortality in Severe Covid-19 Pneumonia Patients, Journal of Clinical Laboratory Analysis (2021)
28. Screening of Potential Inhibitors of Covid-19 With Repurposing Approach Via Molecular Docking, Network Modeling Analysis in Health Informatics and Bioinformatics (2022)
29. Coenzyme Q10 and Its Therapeutic Potencies Against Covid-19 and Other Similar Infections: A Molecular Review, Advanced Pharmaceutical Bulletin (2023)
30. Covid-19 and the Potential of Janus Family Kinase (Jak) Pathway Inhibition: A Novel Treatment Strategy, Frontiers in Medicine (2022)
31. Covid‑19’S Effect in Pregnancy and Vertical Transmission: A Systematic Review, International Journal of Preventive Medicine (2024)
32. The Immune Cells Profiles of Individuals With Sulfur Mustard-Induced Serious Long-Term Respiratory Complications, International Immunopharmacology (2025)
33. Therapeutic Plasma Exchange May Adjust Il-6 and Tgf-Β Signals in Relapsed Ms Patients Peripheral Blood, Journal of Clinical Apheresis (2020)
34. Evaluation of the Effect of Montelukast Drug in Improving the Clinical Condition of Patients With Covid-19 in Referral Hospitals in Isfahan; a Randomized Clinical Trial, Journal of Nephropharmacology (2024)
35. Review on Selected Potential Nutritional Intervention for Treatment and Prevention of Viral Infections: Possibility of Recommending These for Coronavirus 2019, International Journal of Food Properties (2020)
36. Risk Factors, Clinical, and Laboratory Characteristics of Patients With a Diagnosis of Covid-19, Journal of Emergency Practice and Trauma (2022)
37. Pulmonary Function, Anxiety, Depression, and Sleep Quality After Recovery From Covid-19, Tanaffos (2023)
38. Time-Series Bioinformatics Analysis of Sars-Cov-Infected Cells to Identify the Biological Processes Associated With Severe Acute Respiratory Syndrome, Human Antibodies (2024)
39. Prevention of Covid-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions, Advances in Experimental Medicine and Biology (2021)
40. The Severity of Symptoms and Outcomes of Patients Admitted With Rheumatic Diseases and Covid-19; a Prospective Cohort Study in Iran, Immunopathologia Persa (2021)
41. Covid-19 Management in the Emergency Ward, Journal of Research in Medical Sciences (2021)
42. The Frequencies of Peripheral Blood Cd5+Cd19+ B Cells, Cd3−Cd16+Cd56+ Nk, and Cd3+Cd56+ Nkt Cells and Serum Interleukin-10 in Patients With Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder, Allergy, Asthma and Clinical Immunology (2022)
43. Chronic Kidney Disease and Covid-19 Infection: A Case–Control Study, Advanced Biomedical Research (2022)
44. Recent Findings of Coronavirus: The Pathogenesis and Treatment, Journal of Isfahan Medical School (2020)
45. Diagnosis and Treatment of Acute Myocardial Ischemia in Patients With Covid-19 Infection, Journal of Isfahan Medical School (2021)
46. Comparison of Follicular T Helper Cells, Monocytes, and T Cells Priming Between Newly Diagnosed and Rituximab-Treated Ms Patients and Healthy Controls, Research in Pharmaceutical Sciences (2022)
47. Reopening of Dental Clinics During Sars-Cov-2 Pandemic: An Evidence-Based Review of Literature for Clinical Interventions, Maxillofacial Plastic and Reconstructive Surgery (2020)
48. Efficacy of Plasmapheresis in Neutropenic Patients Suffering From Cytokine Storm Because of Severe Covid-19 Infection, Blood Research (2023)
49. Thalidomide for the Treatment of Covid-19 Pneumonia: A Randomized Controlled Clinical Trial, Advanced Biomedical Research (2023)
50. Clinical, Laboratory, and Chest Ct Features of Dead Versus Recovered Coronavirus Disease 2019 (Covid-19) Patients: A Multicenter Study, Journal of Health Sciences and Surveillance System (2023)